Pricing Log in Create free account

Context Therapeutics Inc. (CNTX) vs Pasithea Therapeutics Corp. (KTTA)

Context Therapeutics Inc. and Pasithea Therapeutics Corp. are both Biotechnology companies. Context Therapeutics Inc. and Pasithea Therapeutics Corp. are of similar size ($17.4M and $17.3M). Across the 10 metrics below, Pasithea Therapeutics Corp. leads on 6 and Context Therapeutics Inc. on 4.

Valuation

Metric CNTX KTTA Biotechnology median
P/E n/m n/m 10.60
P/S n/m 38.26 9.40
P/B 0.47 0.37 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.51 1.17 0.66
EV/Sales n/m (55.79) 9.02
Earnings yield (252.63%) (254.86%) (32.88%)
Free cash flow yield (188.15%) (94.76%) (23.13%)

Profitability

Metric CNTX KTTA Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (76.14%) (65.49%) (51.96%)
Return on assets (68.96%) (61.97%) (46.06%)
Return on invested capital 0.00% (367.46%) 0.00%

Growth

Metric CNTX KTTA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 17.39% 77.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CNTX KTTA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.81 26.25 4.97
Net debt to EBITDA 1.66 2.74 1.01

Dividend

Metric CNTX KTTA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CNTX KTTA Biotechnology median
Market cap 17.27m 17.38m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack